Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

<p><strong>BACKGROUND:</strong> There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied whether patients prescribed these drugs had altered risks of contracting severe COVID-19...

Cijeli opis

Bibliografski detalji
Glavni autori: Hippisley-Cox, J, Young, D, Coupland, C, Channon, KM, Tan, PS, Harrison, DA, Rowan, K, Aveyard, P, Pavord, ID, Watkinson, PJ
Format: Journal article
Jezik:English
Izdano: BMJ 2020